Searchable abstracts of presentations at key conferences in endocrinology

ea0063s15.1 | European Young Endocrine Scientists (EYES) | ECE2019

European Young Endocrine Scientists (EYES) – Organ cross-talk in endocrine disease

Aldiss Peter

‘European Young Endocrine Scientists’ (EYES), founded in 2011, is a committee under the patronage of the European Society of Endocrinology (ESE). Our primary goal is to increase the mutual exchange of ideas and knowledge between early career researchers (ECR’s) across Europe, in both basic and clinical endocrinology. EYES enables ECR’s from all ESE member societies to actively contribute to the society’s activities and help them fully develop into the ...

ea0056gp160 | Obesity | ECE2018

Physiological regulation of brown adipose tissue in obesity by mild-cold exposure, a B3-agonist and exercise training at thermoneutrality

Aldiss Peter , Lewis Jo , Ebling Fran , Budge Helen , Symonds Michael

Background: Therapeutic activation of thermogenic brown adipose tissue (BAT) is a potential strategy to prevent obesity and metabolic disease in humans. However, it is now recognised that rodent studies examining BAT physiology are carried out at sub-thermoneutral temperatures (e.g. ~20°C), and are not translationally relevant to humans as BAT is ‘hyperactive’. Therefore, the aim of this study was to determine the effect of common regulators of BAT metabolism wh...

ea0039ep43 | Diabetes | BSPED2015

The effects of CSII on glycaemic control, hypoglycaemia, DKA and BMI in paediatric T1D patients.

Aldiss Peter , Santhanam Priyha , Kumar Kiran , Wolverson Marianne , Randell Tabitha , Denvir Louise , Sachdev Pooja

Background: Current NICE guidance states that insulin pump therapy (CSII) can be considered in Type 1 diabetes (T1DM) patients who suffer disabling hypoglycaemia in an attempt to reach glycaemic control or whose HbA1C remains high (>69 mmol/l) despite careful management on multiple daily injections (MDI).Aims: Our aims were to determine impact of CSII therapy on glycaemic control, BMI, incidence of severe hypoglycaemia and episodes of diabetic ketoac...